By Jim Brewer
CONMED (NASDAQ:CNMD) has received a consensus recommendation of “Hold” from the seven brokerages
that are presently covering the stock, StockRatingsNetwork reports. One analyst has rated the stock with a sell recommendation, two have given a hold recommendation and three have assigned a buy recommendation to the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $53.83.
Shares of CONMED (NASDAQ:CNMD) traded down 0.09% during mid-day trading on Friday, hitting $53.35. The stock had a trading volume of 61,480 shares. CONMED has a 52-week low of $35.85 and a 52-week high of $54.65. The stock has a 50-day moving average of $50. and a 200-day moving average of $46.. The company
has a market cap of $1.47 billion and a price-to-earnings ratio of 49.40.
CONMED (NASDAQ:CNMD) last issued its quarterly earnings data on Wednesday, April 22nd. The company reported $0.42 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.43 by $0.01. The company had revenue of $177.90 million for the quarter, compared to the consensus estimate of $176.16 million. During the same quarter in the prior year, the company posted $0.49 earnings per share. The company’s quarterly revenue was down 2.2% on a year-over-year basis. On average, analysts predict that CONMED will post $1.85 earnings per share for the current fiscal year.
